Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1995 Jun;63(6):2295–2301. doi: 10.1128/iai.63.6.2295-2301.1995

Reactivation of arthritis induced by small bowel bacterial overgrowth in rats: role of cytokines, bacteria, and bacterial polymers.

S N Lichtman 1, J Wang 1, R B Sartor 1, C Zhang 1, D Bender 1, F G Dalldorf 1, J H Schwab 1
PMCID: PMC173300  PMID: 7768612

Abstract

Arthritis is often associated with intestinal diseases, but the etiology is not known. We developed a rat model whereby arthritis was reactivated by experimental small bowel bacterial overgrowth (SBBO). Self-limited monoarticular arthritis was induced by intra-articular injection of 2 micrograms of rhamnose peptidoglycan-polysaccharide derived from group A streptococci into the ankle joints in female Lewis rats. Eleven days after intra-articular injection, when swelling was resolving, experimental SBBO induced by surgical creation of jejunal self-filling blind loops reactivated arthritis, but SBBO induced by creation of self-emptying blind loops, which minimally increases luminal bacteria, and sham operation did not (P < 0.001). Increased joint diameters in rats with self-filling blind loops persisted for at least 56 days after surgery. Reactivation of arthritis due to SBBO was prevented by anti-tumor necrosis factor alpha antiserum and interleukin 1 receptor antagonist (P < 0.001), indicating that these cytokines mediate joint swelling secondary to intestinal injury. Recombinant bactericidal/permeability-increasing protein, an agent which neutralizes endotoxin, and metronidazole, which is active against anaerobic bacteria, prevented arthritis (P < 0.001), but polymyxin B (which also neutralizes endotoxin) and gentamicin had no effect. Mutanolysin, an enzyme which degrades peptidoglycan-polysaccharide from group A streptococci, exacerbated arthritis for the first 6 days but then diminished joint swelling from 12 to 21 days after surgery (P < 0.001). These studies introduce a reproducible animal model of reactivation of arthritis secondary to intestinal injury and demonstrate a role for bacterial products from endogenous enteric organisms.

Full Text

The Full Text of this article is available as a PDF (673.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arndt H., Palitzsch K. D., Grisham M. B., Granger D. N. Metronidazole inhibits leukocyte-endothelial cell adhesion in rat mesenteric venules. Gastroenterology. 1994 May;106(5):1271–1276. doi: 10.1016/0016-5085(94)90019-1. [DOI] [PubMed] [Google Scholar]
  2. Baumgartner J. D., Heumann D., Gerain J., Weinbreck P., Grau G. E., Glauser M. P. Association between protective efficacy of anti-lipopolysaccharide (LPS) antibodies and suppression of LPS-induced tumor necrosis factor alpha and interleukin 6. Comparison of O side chain-specific antibodies with core LPS antibodies. J Exp Med. 1990 Mar 1;171(3):889–896. doi: 10.1084/jem.171.3.889. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cromartie W. J., Craddock J. G., Schwab J. H., Anderle S. K., Yang C. H. Arthritis in rats after systemic injection of streptococcal cells or cell walls. J Exp Med. 1977 Dec 1;146(6):1585–1602. doi: 10.1084/jem.146.6.1585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Esser R. E., Stimpson S. A., Cromartie W. J., Schwab J. H. Reactivation of streptococcal cell wall-induced arthritis by homologous and heterologous cell wall polymers. Arthritis Rheum. 1985 Dec;28(12):1402–1411. doi: 10.1002/art.1780281213. [DOI] [PubMed] [Google Scholar]
  5. Finch W. Arthritis and the gut. Postgrad Med. 1989 Aug;86(2):229-30, 233-4. doi: 10.1080/00325481.1989.11704368. [DOI] [PubMed] [Google Scholar]
  6. Gazzano-Santoro H., Parent J. B., Grinna L., Horwitz A., Parsons T., Theofan G., Elsbach P., Weiss J., Conlon P. J. High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide. Infect Immun. 1992 Nov;60(11):4754–4761. doi: 10.1128/iai.60.11.4754-4761.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Granfors K., Jalkanen S., von Essen R., Lahesmaa-Rantala R., Isomäki O., Pekkola-Heino K., Merilahti-Palo R., Saario R., Isomäki H., Toivanen A. Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. N Engl J Med. 1989 Jan 26;320(4):216–221. doi: 10.1056/NEJM198901263200404. [DOI] [PubMed] [Google Scholar]
  8. Greenman R. L., Schein R. M., Martin M. A., Wenzel R. P., MacIntyre N. R., Emmanuel G., Chmel H., Kohler R. B., McCarthy M., Plouffe J. A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group. JAMA. 1991 Aug 28;266(8):1097–1102. [PubMed] [Google Scholar]
  9. Grove D. I., Mahmound A. A., Warren K. S. Suppression of cell-mediated immunity by metronidazole. Int Arch Allergy Appl Immunol. 1977;54(5):422–427. doi: 10.1159/000231857. [DOI] [PubMed] [Google Scholar]
  10. Harkonen S., Scannon P., Mischak R. P., Spitler L. E., Foxall C., Kennedy D., Greenberg R. Phase I study of a murine monoclonal anti-lipid A antibody in bacteremic and nonbacteremic patients. Antimicrob Agents Chemother. 1988 May;32(5):710–716. doi: 10.1128/aac.32.5.710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hill J. L., Yu D. T. Development of an experimental animal model for reactive arthritis induced by Yersinia enterocolitica infection. Infect Immun. 1987 Mar;55(3):721–726. doi: 10.1128/iai.55.3.721-726.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Janusz M. J., Chetty C., Eisenberg R. A., Cromartie W. J., Schwab J. H. Treatment of experimental erosive arthritis in rats by injection of the muralytic enzyme mutanolysin. J Exp Med. 1984 Nov 1;160(5):1360–1374. doi: 10.1084/jem.160.5.1360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Keat A. Reiter's syndrome and reactive arthritis in perspective. N Engl J Med. 1983 Dec 29;309(26):1606–1615. doi: 10.1056/NEJM198312293092604. [DOI] [PubMed] [Google Scholar]
  14. Keat A., Thomas B., Dixey J., Osborn M., Sonnex C., Taylor-Robinson D. Chlamydia trachomatis and reactive arthritis: the missing link. Lancet. 1987 Jan 10;1(8524):72–74. doi: 10.1016/s0140-6736(87)91910-6. [DOI] [PubMed] [Google Scholar]
  15. Kelly C. J., Cech A. C., Argenteanu M., Gallagher H., Shou J., Minnard E., Daly J. M. Role of bactericidal permeability-increasing protein in the treatment of gram-negative pneumonia. Surgery. 1993 Aug;114(2):140–146. [PubMed] [Google Scholar]
  16. Lichtman S. N., Keku J., Schwab J. H., Sartor R. B. Evidence for peptidoglycan absorption in rats with experimental small bowel bacterial overgrowth. Infect Immun. 1991 Feb;59(2):555–562. doi: 10.1128/iai.59.2.555-562.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lichtman S. N., Keku J., Schwab J. H., Sartor R. B. Hepatic injury associated with small bowel bacterial overgrowth in rats is prevented by metronidazole and tetracycline. Gastroenterology. 1991 Feb;100(2):513–519. doi: 10.1016/0016-5085(91)90224-9. [DOI] [PubMed] [Google Scholar]
  18. Lichtman S. N., Okoruwa E. E., Keku J., Schwab J. H., Sartor R. B. Degradation of endogenous bacterial cell wall polymers by the muralytic enzyme mutanolysin prevents hepatobiliary injury in genetically susceptible rats with experimental intestinal bacterial overgrowth. J Clin Invest. 1992 Oct;90(4):1313–1322. doi: 10.1172/JCI115996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lichtman S. N., Sartor R. B., Keku J., Schwab J. H. Hepatic inflammation in rats with experimental small intestinal bacterial overgrowth. Gastroenterology. 1990 Feb;98(2):414–423. doi: 10.1016/0016-5085(90)90833-m. [DOI] [PubMed] [Google Scholar]
  20. Lichtman S. N., Wang J., Schwab J. H., Lemasters J. J. Comparison of peptidoglycan-polysaccharide and lipopolysaccharide stimulation of Kupffer cells to produce tumor necrosis factor and interleukin-1. Hepatology. 1994 Apr;19(4):1013–1022. [PubMed] [Google Scholar]
  21. McCall R. D., Haskill S., Zimmermann E. M., Lund P. K., Thompson R. C., Sartor R. B. Tissue interleukin 1 and interleukin-1 receptor antagonist expression in enterocolitis in resistant and susceptible rats. Gastroenterology. 1994 Apr;106(4):960–972. doi: 10.1016/0016-5085(94)90755-2. [DOI] [PubMed] [Google Scholar]
  22. Neumann V., Wright V. Arthritis associated with bowel disease. Clin Gastroenterol. 1983 Sep;12(3):767–795. [PubMed] [Google Scholar]
  23. Ooi C. E., Weiss J., Doerfler M. E., Elsbach P. Endotoxin-neutralizing properties of the 25 kD N-terminal fragment and a newly isolated 30 kD C-terminal fragment of the 55-60 kD bactericidal/permeability-increasing protein of human neutrophils. J Exp Med. 1991 Sep 1;174(3):649–655. doi: 10.1084/jem.174.3.649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Schwab J. H., Anderle S. K., Brown R. R., Dalldorf F. G., Thompson R. C. Pro- and anti-inflammatory roles of interleukin-1 in recurrence of bacterial cell wall-induced arthritis in rats. Infect Immun. 1991 Dec;59(12):4436–4442. doi: 10.1128/iai.59.12.4436-4442.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Schwab J. H., Brown R. R., Anderle S. K., Schlievert P. M. Superantigen can reactivate bacterial cell wall-induced arthritis. J Immunol. 1993 May 1;150(9):4151–4159. [PubMed] [Google Scholar]
  26. Schwab J. H. Phlogistic properties of peptidoglycan-polysaccharide polymers from cell walls of pathogenic and normal-flora bacteria which colonize humans. Infect Immun. 1993 Nov;61(11):4535–4539. doi: 10.1128/iai.61.11.4535-4539.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Sherman P., Lichtman S. Small bowel bacterial overgrowth syndrome. Dig Dis. 1987;5(3):157–171. doi: 10.1159/000171170. [DOI] [PubMed] [Google Scholar]
  28. Sherry B. A., Gelin J., Fong Y., Marano M., Wei H., Cerami A., Lowry S. F., Lundholm K. G., Moldawer L. L. Anticachectin/tumor necrosis factor-alpha antibodies attenuate development of cachexia in tumor models. FASEB J. 1989 Jun;3(8):1956–1962. doi: 10.1096/fasebj.3.8.2721856. [DOI] [PubMed] [Google Scholar]
  29. Stein H. B., Schlappner O. L., Boyko W., Gourlay R. H., Reeve C. E. The intestinal bypass: arthritis-dermatitis syndrome. Arthritis Rheum. 1981 May;24(5):684–690. doi: 10.1002/art.1780240509. [DOI] [PubMed] [Google Scholar]
  30. Stimpson S. A., Brown R. R., Anderle S. K., Klapper D. G., Clark R. L., Cromartie W. J., Schwab J. H. Arthropathic properties of cell wall polymers from normal flora bacteria. Infect Immun. 1986 Jan;51(1):240–249. doi: 10.1128/iai.51.1.240-249.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Stimpson S. A., Dalldorf F. G., Otterness I. G., Schwab J. H. Exacerbation of arthritis by IL-1 in rat joints previously injured by peptidoglycan-polysaccharide. J Immunol. 1988 May 1;140(9):2964–2969. [PubMed] [Google Scholar]
  32. Stimpson S. A., Esser R. E., Carter P. B., Sartor R. B., Cromartie W. J., Schwab J. H. Lipopolysaccharide induces recurrence of arthritis in rat joints previously injured by peptidoglycan-polysaccharide. J Exp Med. 1987 Jun 1;165(6):1688–1702. doi: 10.1084/jem.165.6.1688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Taurog J. D., Richardson J. A., Croft J. T., Simmons W. A., Zhou M., Fernández-Sueiro J. L., Balish E., Hammer R. E. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med. 1994 Dec 1;180(6):2359–2364. doi: 10.1084/jem.180.6.2359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Van den Broek M. F., Van de Putte L. B., Van den Berg W. B. Crohn's disease associated with arthritis: a possible role for cross-reactivity between gut bacteria and cartilage in the pathogenesis of arthritis. Arthritis Rheum. 1988 Aug;31(8):1077–1079. doi: 10.1002/art.1780310825. [DOI] [PubMed] [Google Scholar]
  35. Yu D. T., Choo S. Y., Schaack T. Molecular mimicry in HLA-B27-related arthritis. Ann Intern Med. 1989 Oct 1;111(7):581–591. doi: 10.7326/0003-4819-111-7-581. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES